Lipitor lawsuit claims alleging the cholesterol drug’s potential to cause type-2 diabetes have been consolidated in a federal proceeding now underway in the U.S. District Court, Southern District of Illinois, according to court records.
Cases in the proceeding, which was established on October 7th claim that Pfizer Inc. failed to warn about the diabetes risks associated with Lipitor, a cholesterol-lowering medication. At the time this litigation was created, a federal judge overseeing Lipitor diabetes cases noted that 14 claims had been filed in the District of South Carolina. Given that information, the number of Lipitor diabetes lawsuits is likely to grow.
According to a petition filed with attorneys for plaintiffs, there are “hundreds of cases under review, with a significant number of cases potentially appropriate for filing in the Southern District of Illinois.” Despite the recent establishment of a federal proceeding, a Lipitor recall has not been announced.
Concerns about Lipitor have gained momentum over the past year. In February 2012, Pfizer was ordered by the U.S. Food and Drug Administration (FDA) to include type-2 diabetes as a possible side effect of the drug after a study in JAMA: Internal Medicine revealed that post-menopausal women may be more likely to develop type-2 diabetes. The British Medical Journal later strengthened the Lipitor diabetes connection after finding that users were 22 percent more likely to develop the illness.
It is noteworthy to add that in August, the U.S. Judicial Panel on Multidistrict Litigation rejected a proposal to create a multidistrict litigation for Lipitor lawsuits, but acknowledged that the makers of Lipitor had been willing to consolidate claims in a single federal court.
A growing number of individuals in the U.S. are coming forward to file Lipitor lawsuits alleging injuries caused by the medication used to treat patients with high cholesterol. By filing a case, you may be eligible to receive compensation for medical expenses, lost wages, and other out-of-pocket expenses associated with your injuries. Bernstein Liebhard LLP is currently offering free case reviews to patients who may have developed type-2 diabetes, kidney or liver damage, as well as skeletal muscle side effects, known as myopathy and rhabdomyolysis after taking Lipitor. Call to find out more about your legal options at .